Clinical Trial Update: A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome

View source ↗

Summary

The long-term study evaluating cholesterol supplementation for Smith-Lemli-Opitz syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smith-lemli-opitz Syndrome

Drugs mentioned

• Cholesterol supplements (cholesterol supplement)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Smith-Lemi-Opitz Syndrome | Status: WITHDRAWN